Tradestie Institutional Equity Comparison Engine
KTTA vs OLB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
KTTA Overall Edge
KTTA Captures Institutional Edge (2โ0 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pasithea Therapeutics Corp. Common Stock (KTTA) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, KTTA trades at N/M Forward P/E with 0.0% operating margin (+1498.1% YoY revenue) versus OLB at N/M Forward P/E and -73.3% operating margin (-43.6% YoY). In options structure, KTTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OLB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
KTTA N/M vs OLB N/M Fwd P/E
Growth & Margin Winner
KTTA
Op Margin 0.0% vs -73.3% ยท YoY +1498.1% vs -43.6%
Momentum & Technical Winner
KTTA
1Y +0.6% vs -87.4% ยท 52W Pos 11% vs 0%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
KTTA
NASDAQ
Pasithea Therapeutics Corp. Common Stock
Pharmaceutical Preparations
$0.48
-0.48% 1D
Market Cap
$17.7M
1M Return
+7.52%
1Y Return
+0.59%
Forward P/E
N/M
Unified AI Score
42.1 / 100
HOLD
Tech 20.0
Fund 40.0
Flow 50.0
Mom 60.0
OLB
NASDAQ
The OLB Group, Inc. Common Stock
Services-Business Services, Nec
$0.12
-4.33% 1D
Market Cap
$3.8M
1M Return
-63.26%
1Y Return
-87.36%
Forward P/E
N/M
Unified AI Score
48.6 / 100
HOLD
Tech 48.0
Fund 46.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
KTTA +0.59%
OLB -87.36%
Spread: +87.95 pp (KTTA Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | KTTA Revenue | OLB Revenue | KTTA Op. Margin | OLB Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $10M | N/A | 5.9% | OLB |
| FY2019 | N/A | $10M | N/A | -2.6% | OLB |
| FY2020 | N/A | $10M | N/A | -7.5% | OLB |
| FY2021 | $0M | $20M | -29925.7% | -28.5% | OLB |
| FY2022 | $0M | $30M | -2587.3% | -26.9% | OLB |
| FY2023 | N/A | $30M | N/A | -76.8% | OLB |
| FY2024 | N/A | $10M | N/A | -90.9% | OLB |
| FY2025 | N/A | $10M | N/A | -59.5% | OLB |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | KTTA | OLB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $17.7M | $3.8M | Larger Scale | KTTA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +1498.1% | -43.6% | Higher Growth | KTTA |
| Operating Margin (TTM) Profitability | 0.0% | -73.3% | Higher Margin | KTTA |
| Net Profit Margin Profitability | 0.0% | -68.2% | Higher Margin | KTTA |
| Return on Equity (ROE) Capital Efficiency | -88.8% | -70.8% | Higher ROE | OLB |
| 52-Week Range Position Momentum | 11% ($0โ$2) | 0% ($0โ$2) | Stronger Trend | KTTA |
| Beta / 30D Volatility Risk Regime | 0.68ฮฒ ยท 185% Vol | 1.80ฮฒ ยท 120% Vol | Lower Realized Risk | OLB |
| Unified Institutional Score Composite Signal | 42.1 / 100 (HOLD) | 48.6 / 100 (HOLD) | Higher Composite | OLB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full KTTA vs OLB Buy Guide
KTTA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
OLB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither KTTA nor OLB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.